Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach Z Molavi, S Razi, SA Mirmotalebisohi, A Adibi, M Sameni, F Karami, ... Biomedicine & Pharmacotherapy 138, 111544, 2021 | 53 | 2021 |
Clinical applications and anticancer effects of antimicrobial peptides: from bench to bedside A Jafari, A Babajani, R Sarrami Forooshani, M Yazdani, ... Frontiers in oncology 12, 819563, 2022 | 50 | 2022 |
Virtual Dual inhibition of COX-2/5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug MM Ranjbar, V Assadolahi, M Yazdani, D Nikaein, B Rashidieh EXCLI journal 15, 238, 2016 | 26 | 2016 |
FDA approved drugs repurposing of Toll-like receptor4 (TLR4) candidate for neuropathy H Zali, A Golchin, M Farahani, M Yazdani, MM Ranjbar, A Dabbagh Iranian Journal of Pharmaceutical Research: IJPR 18 (3), 1639, 2019 | 24 | 2019 |
Cancer care management during the COVID-19 pandemic A Jafari, M Rezaei-Tavirani, S Karami, M Yazdani, H Zali, Z Jafari Risk Management and Healthcare Policy, 1711-1721, 2020 | 16 | 2020 |
Mesenchymal stem cells in the treatment of new coronavirus pandemic: a novel promising therapeutic approach S Razi, Z Molavi, SA Mirmotalebisohi, Z Niknam, M Sameni, V Niazi, ... Advanced Pharmaceutical Bulletin 12 (2), 206, 2022 | 7 | 2022 |
Rational approaches to discover SARS-CoV-2/ACE2 interaction inhibitors: pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies M Yazdani, A Jafari, S Mahdian, M Namazi, S Gharaghani Journal of Molecular Liquids, 121345, 2023 | 5 | 2023 |
Newly identified COVID-19 drug candidates based on computational strategies P Azerang, M Yazdani, K RayatSanati, A Tahghighi Journal of Computational Biophysics and Chemistry 21 (01), 123-137, 2022 | 4 | 2022 |
Structure-based virtual screening and molecular dynamics approaches to identify new inhibitors of Staphylococcus aureus sortase A MA Mahmood Janlou, H Sahebjamee, M Yazdani, L Fozouni Journal of Biomolecular Structure and Dynamics, 1-13, 2023 | 2 | 2023 |
Identification of the crucial regulatory elements modulating the host respiratory response to SARS-CoV-2 using motif detection, a systems biology approach SA Mirmotalebisohi, Z Molavi, S Razi, M Sameni, F Karami, M Yazdani, ... Journal of" Regeneration, Reconstruction & Restoration"(Triple R) 5, e4-e4, 2020 | 2 | 2020 |
Synthesis, in silico studies, and in vitro biological evaluation of newly-designed 5-amino-1H-tetrazole-linked 5-fluorouracil analog as a potential antigastric-cancer … J Nowdehi, E Mosaddegh, S Khaksar, M Torkzadeh-Mahani, M Beihaghi, ... Journal of Biomolecular Structure and Dynamics, 1-19, 2024 | 1 | 2024 |
Unveiling Diagnostic and Therapeutic Strategies for Cervical Cancer: Biomarker Discovery through Proteomics Approaches and Exploring the Role of Cervical Cancer Stem Cells A Jafari, M Abdollahpour-Alitappeh, A Manzari-Tavakoli, M Yazdani, ... Frontiers in Oncology 13, 1277772, 2024 | 1 | 2024 |
Inhibitory Effects of Dutasteride on TLR4: An In vitro Pain Study L Taheran, H Zali, K Sharifi, M Yazdani, M Ajoudanian, MS Safari, ... Iranian Journal of Allergy, Asthma and Immunology 21 (5), 574-583, 2022 | 1 | 2022 |
Anti-quorum sensing effects of SidA protein on Escherichia coli receptors: in silico analysis M Yazdani, M Beihaghi, N Ataee, M Zabetian, S Khaksar, H Nasrizadeh, ... Journal of Biomolecular Structure and Dynamics, 1-12, 2024 | | 2024 |
Discovery of potential inhibitor against human Asparagine Endopeptidase Z Nayeria, F Afzali, M Yazdani International Pharmacy Acta 1 (1), 89-89, 2018 | | 2018 |
INEVITABLE EMPLOYING COMPUTATIONAL METHODS AND MOLECULAR MODELING TO ACHIEVE NOVEL ANTICANCER MEDICINE A LARI, M HAGHKHAH, M YAZDANI ZANKO JOURNAL OF MEDICAL SCIENCES 17 (55), 79-89, 2017 | | 2017 |
Developing consensus QSAR models of Naphthyridine analogues as anti HIV-1 integrase activity M Zakariazadeh, A Barzegar, S Soltani, M Yazdani, H Aryapour 1st Tabriz International Life Science Conference and 12th Iran Biophysical …, 2013 | | 2013 |
MOLECULAR DOCKING STUDIES OF SOME COUMARIN DERIVATIVES AS β-SECRETASE) BACE1) INHIBITORS M YAZDANI, FMALI HOSEINPOUR, A BARZEGAR | | 2012 |
Identification of a nonpeptide cyclic urea inhibitor of HIV protease using in silico molecular docking M Yazdani, M Masomi Clinical Biochemistry 13 (44), S321-S322, 2011 | | 2011 |